CHPA “Neutral” On Requiring Deadlines For TEA Reviews
This article was originally published in The Tan Sheet
Executive Summary
CHPA comments on the Senate HELP Committee’s draft legislation to require FDA to establish review deadlines for TEAs. The trade group says it is “neutral” about the suggestion, but offers to help the committee with “more comprehensive reviews of OTC approvals.”